Immunization Programs Professors and Supervisors | ApplySharif

Find Academic Supervisors

Find and connect with academic supervisors, professors, and scholars for your research journey.

Showing 706-720 of 10,772 supervisors

Profile data may be stale. It is sourced from public faculty pages.

Russell JonesView profile

Professor

Van Andel InstituteUnited States

Dr. Russell Jones is a Professor and Chair of the Department of Metabolism and Nutritional Programming at Van Andel Research Institute (VAI). His research focuses on cancer metabolism, immunology, and the interplay between cellular metabolism and immune function, with a particular emphasis on understanding how metabolic pathways influence tumor growth and anti-tumor immune responses. Dr. Jones earned his B.Sc. and Ph.D. in Biochemistry and Medical Biophysics from the University of Toronto, followed by postdoctoral training at the University of Pennsylvania. He has held academic positions at McGill University and VARI, where he leads a team investigating immunometabolism and cancer metabolism. His work bridges basic research and clinical translation, aiming to develop novel therapies targeting metabolic vulnerabilities in cancer cells and immune cells. His research interests include tumor immunology, metabolic reprogramming in T cells, and the role of metabolic checkpoints in cancer progression. Notable achievements include discovering mechanisms linking LKB1 mutations to gastrointestinal polyposis and identifying metabolic pathways critical for T cell function in tumor microenvironments. Dr. Jones has been recognized with awards such as the William Dawson Scholar distinction and election to the Royal Society of Canada. He serves on editorial boards of leading journals and actively contributes to clinical trials through collaborations with institutions like VAI-SU2C Epigenetics Dream Team. His laboratory is part of VAI’s Center for Cancer and Cell Biology, emphasizing interdisciplinary approaches to metabolism and nutrition. Current projects explore how metabolic interventions can enhance immunotherapy efficacy and uncover metabolic dependencies in cancer cells.

Official University Profile

Dario GhersiView profile

Associate Professor

University of Nebraska at OmahaUnited States

Dario Ghersi is Associate Professor and Graduate Program Chair for Biomedical Informatics, Cybersecurity, and IT Innovation at UNO's College of Information Science & Technology. He holds an MD from the University of Genoa and a PhD in Structural Bioinformatics from Mount Sinai School of Medicine. Research focuses on cancer genomics, structural bioinformatics, immunoinformatics, and biologically-inspired computing. His lab develops computational methods for understanding protein interactions, T-cell immunity, and therapeutic design. Recent publications demonstrate advancements in viral inhibition strategies, equitable algorithm design, and cancer biomarker discovery. Awards include a 2011 American-Italian Cancer Foundation fellowship. Service includes co-directing the BISB track in the IGPBS PhD program and multiple committee roles.

Official University Profile

Gabriel LoebView profile

Assistant Professor

University of California, San FranciscoUnited States

Gabriel Loeb, MD, PhD is an Assistant Professor at the University of California, San Francisco (UCSF) School of Medicine , where he operates as a physician-scientist specializing in genetic kidney diseases . His research integrates human genetics , genomics , and novel kidney disease models to identify molecular mechanisms in chronic kidney disease and Autosomal Dominant Polycystic Kidney Disease (ADPKD). Clinically, he focuses on familial and genetic kidney disease care at the UCSF Nephrology Faculty Practice . Education BS in Biology (2005), Stanford University MD (2015), Cornell PhD in Immunology (2015), Cornell/Rockefeller/Sloan Kettering Internal Medicine Residency (2018), Brigham and Women's Hospital/Harvard Medical School Nephrology Fellowship (2021), UCSF Research Interests center on leveraging human genetic variation to decode kidney disease mechanisms, with a focus on ADPKD and tubule epithelial regulatory elements . His work explores cell type-specific genomics , polycystin channel function , and urine multiomics for non-invasive diagnostics. Recent Publications highlight advancements in ADPKD mechanistic understanding , urine-based liquid biopsies , and genomic deep learning model limitations . Key journals include Nature Genetics , Nature Communications , and bioRxiv . Grants & Programs Laboratory for Genomics Research Innovation Award (2024–2025) Physician Scientist Scholars Program, UCSF (2021–2026)

Official University Profile

Leonie YoungView profile

Professor

Royal College of Surgeons in IrelandIreland

Professor Leonie Young holds a Professorship in the Department of Surgery at the Royal College of Surgeons in Ireland (RCSI), based at York House in Dublin. Her academic career includes roles as Associate Professor (2011–2018) and Professor (2018–present). Her research focuses on uncovering mechanisms of endocrine therapy resistance in breast cancer, particularly involving Steroid Receptor Coactivator (SRC) proteins and metastasis to the brain. She leads the Endocrine Oncology Research Group, leveraging primary patient-derived cell cultures and clinical datasets to identify predictive markers and therapeutic targets. Research Interests: Prof. Young’s work spans breast cancer biology, endocrine resistance, translational oncology, and targeted therapies for metastatic disease. Her group employs high-throughput methods, molecular modeling, and spatial genomics to study SRC-mediated resistance pathways. Current projects include the GeTTMet initiative addressing brain metastasis through genomic adaptations. Grants & Collaborations: She has secured funding from institutions like Science Foundation Ireland, Breast Cancer Ireland, and the EU. Notable grants include the GeTTMet program (2024–2028) targeting brain metastasis via genomic approaches. Her lab collaborates on projects like the OECI Comprehensive Cancer Centre and AICRIstart precision medicine initiatives. Labs & Teams: Leads the Endocrine Oncology Research Group at RCSI, focusing on translational research to bridge molecular insights with clinical applications. The group investigates nuclear receptor interactions, tumor heterogeneity, and novel therapeutic strategies.

Official University Profile

Antony RodriguezView profile

Associate Professor

Baylor College of MedicineUnited States

Antony Rodriguez, Ph.D., is an Associate Professor at Baylor College of Medicine, affiliated with the Department of Immunology, Allergy & Rheumatology and the Center for Translational Research on Inflammatory Diseases (CTRID). He holds roles as a Graduate Faculty Member in Immunology & Microbiology and Development, Disease Models & Therapeutics. His laboratory focuses on microRNA-mediated mechanisms in lung physiology and repair, particularly in COPD and interstitial lung disease (ILD). Education includes a PhD in Genetics, Development, and Programmed Cell Death from the University of Texas Southwestern Medical Center, followed by a postdoctoral fellowship at the Wellcome Trust Sanger Institute focusing on microRNAs, immunology, and stem cells. Research interests center on microRNA regulation of lung repair, stem cell dysfunction, and inflammation-driven injury. Key projects include let-7 miRNA's role in Tc17 differentiation and fibrogenic pathways. Techniques used include chimeric AGO2-eCLIP, single-cell RNA sequencing (scRNA-seq), and CUT&RUN. Active NIH-funded projects (NHLBI) investigate let-7's role in lung disease pathogenesis and AT2 cell homeostasis. No scientific awards are explicitly listed in the provided text. His work bridges basic science and translational medicine, aiming to develop novel therapies for severe lung diseases such as COPD and ILD.

Official University Profile

Sarhad AlnajjarView profile

Lecturer

University of SurreyUnited Kingdom

Dr. Sarhad Alnajjar is a Lecturer in Veterinary Pathology at the University of Surrey's School of Veterinary Medicine, Department of Veterinary Pathology Centre. He holds a Ph.D. in Veterinary Pathology from Iowa State University (USA), with a minor in Microbiology and Immunobiology, and completed a veterinary pathology residency. His prior roles include teaching veterinary pathology at the University of Baghdad. Research focuses on infectious diseases and zoonotic pathogens via a One Health approach. Current projects involve testing antiviral compounds for Respiratory Syncytial Virus (RSV) in neonatal lamb models and developing Human Metapneumovirus models in collaboration with Lambcure LLC and pharmaceutical partners. He has pioneered the neonatal lamb model for RSV research, emphasizing translational therapeutics. Teaching responsibilities include module leadership for VMS2005 and VMS2007 in the second-year veterinary curriculum. He has completed teaching certifications including Iowa State University's Preparing Future Faculty (PFF) and CIRTL programs. Publications span RSV pathogenesis, antiviral efficacy, bacterial coinfections, and veterinary pathology models. His work bridges clinical veterinary medicine with biomedical research, emphasizing animal models for human disease.

Official University Profile

Ambrose AgweyuView profile

Professor

Institute of Hygiene and Tropical MedicinePortugal

Professor Ambrose Agweyu is a faculty member at the London School of Hygiene & Tropical Medicine (LSHTM), specifically within the Department of Infectious Disease Epidemiology and International Health under the Faculty of Epidemiology and Population Health. He specializes in pediatric and infectious disease epidemiology, with a focus on global health challenges in Africa. His research addresses gaps in understanding pneumonia mortality disparities, health policy adaptation, and vaccine efficacy through large-scale studies like the SEARCH trial and the Kenya Multi-Site Serosurveillance (KEMIS) collaboration. Professor Agweyu also explores the intersection of dietary aflatoxin exposure and severe childhood pneumonia, contributing to evidence-based health interventions. His work emphasizes integrating routine health services with research and surveillance, particularly in low-resource settings. Notable projects include adapting WHO guidelines for pneumonia risk stratification in Kenya and evaluating HIV prevention knowledge in postconflict regions of South Sudan. Agweyu collaborates closely with institutions such as the Kenya Medical Research Institute (KEMRI) and has contributed to high-impact publications in BMJ , The Lancet , and BMC Infectious Diseases . His research aims to strengthen health systems through improved data utilization, advocacy, and policy implementation, addressing both immediate pandemic responses and long-term childhood health challenges. While no formal academic awards are explicitly listed, his leadership in pivotal studies and his inaugural lecture at LSHTM underscore his contributions to advancing global health equity. His advisory and grant-related activities remain unspecified in the provided texts, though his collaborations and trials imply significant institutional support. Agweyu’s work is deeply embedded in African health systems, with a particular focus on Kenya, aiming to reduce preventable mortality and improve healthcare outcomes through innovative methodologies and policy-oriented research.

Official University Profile

Nidhi SofatView profile

Professor

St George's, University of LondonUnited Kingdom

Professor Nidhi Sofat is a Professor of Rheumatology at St George's, University of London, and a Consultant Rheumatologist at St George's University Hospitals NHS Foundation Trust. She leads the NIHR Integrated Academic Programme for Clinical Academic Trainees, overseeing research and training programs such as the PGCert in Research Skills and Methods. She qualified in medicine from University College London (1996) with First Class Honours, completed specialist rheumatology training in 2007, and earned her PhD from the Kennedy Institute of Rheumatology (Imperial College London). Her research focuses on understanding pain and inflammation in musculoskeletal diseases, particularly osteoarthritis and rheumatoid arthritis. Her group pioneered the Osteoarthritis Bone Score (OABS), the first histological scoring system for bone marrow lesions in osteoarthritis. Key research areas include mechanisms of pain sensitization, imaging techniques (MRI), clinical trials (e.g., DUPRO, PAPO), and collaborations with institutions like the University of Nottingham and Royal Veterinary College. She has received awards such as the Michael Mason Prize (2013) and Wellcome Trust Fellowship (2003). Her clinical roles include managing general rheumatology, inflammatory arthritis, and osteoarthritis at the Hotung Centre. She has contributed to national guidelines via the Arthritis and Musculoskeletal Alliance (ARMA) and served on committees like the British Society for Rheumatology's Heberden Committee. Major grants include funding from NIHR, Versus Arthritis, and the Wellcome Trust. Collaborations span academic and industry partners, including Pfizer and Merck. Her translational research facility bridges clinical and experimental work, aiming to improve diagnostic tools and therapies for arthritis.

Official University Profile

Scott Richard FloydView profile

Associate Professor

Duke UniversityUnited States

Scott Richard Floyd is the Gary Hock and Lyn Proctor Associate Professor of Radiation Oncology at Duke University School of Medicine, with secondary appointments as Associate Professor of Radiation Oncology and Assistant Research Professor in Pharmacology and Cancer Biology. He is also a Member of the Duke Cancer Institute and serves as Associate Radiation Director of the Duke Center for Brain and Spine Metastasis and Associate Program Director of the Duke Radiation Oncology Residency Program. Dr. Floyd received his M.D. and Ph.D. from Yale University in 2002. His professional training includes: Internship in Internal Medicine at Hospital of Saint Raphael (2002-2003) Residency in Radiation Oncology at Harvard Medical School, Harvard Radiation Oncology Program (2003-2007) Clinical Investigator position at MIT Koch Institute for Integrative Cancer Research (2012-) Dr. Floyd's research focuses on DNA damage signaling and repair in brain tumor cells, particularly investigating how chromatin changes mediated by epigenetic modifiers affect the DNA damage response (DDR). His lab develops small animal irradiation techniques and mouse models of glioblastoma to test the effects of epigenetic writers and readers on DDR in clinically relevant model systems. He aims to identify strategies to enhance tumor cell killing while protecting normal brain tissues from radiation damage. His work on brain slice models provides a platform for studying stroke, Alzheimer's disease, Huntington's disease, and brain tumors while reducing animal use. Analysis of Dr. Floyd's recent publications reveals a strong focus on brain metastases, radiation necrosis, and the application of artificial intelligence in radiation oncology. His work increasingly integrates radiogenomics, machine learning, and novel radiation techniques to improve outcomes for patients with brain tumors. There's a clear trend toward interdisciplinary collaboration, particularly in combining radiation therapy with immunotherapy and targeted agents, as evidenced by his leadership in the Consortium for Intracranial Metastasis Academic Research (CIMARa). Dr. Floyd has secured significant research funding, including: NEUROD1 function in SCLC fate and plasticity (NIH, 2024-2029) Synthetic lethality with BET bromodomain inhibition (American Cancer Society, 2025-2026) ASPET SURF Institutional Award (2018-2028) Multiple NIH R01 grants supporting his research on DNA damage response and brain tumor biology Dr. Floyd leads the Floyd Lab, which focuses on studying mechanisms of DNA damage signaling and repair in brain tumor and other mammalian cells. His lab utilizes advanced techniques including small animal irradiation, mouse models of glioblastoma, and organotypic brain slice culture platforms. He is also involved in Project Brainslice, which develops experimental model systems using brain slices to research new treatments for brain diseases. His clinical expertise centers on the treatment of benign, primary, and metastatic tumors of the brain and spine, making him a key figure in Duke's brain and spine metastasis program.

Official University Profile

Nilay PatelView profile

Associate Professor

California State University, FullertonUnited States

Dr. Nilay Patel is an Associate Professor in the Department of Biological Science at California State University, Fullerton (CSUF). His research focuses on drug discovery, particularly the anti-proliferative effects of niclosamide and related compounds on cancer cells, with collaborations in chemistry and biochemistry. He investigates signal transduction pathways and gene expression regulation in cell cycle processes. Dr. Patel teaches courses in cellular/molecular biology, stem cell biology, and related advanced topics. Education: PhD, The State University of New York, Stony Brook BS, University of Cincinnati Research Interests: Design and testing of anti-cancer compounds targeting β-catenin reduction Impact of signal transduction pathways on cancer proliferation Collaborative drug development with CSUF Chemistry & Biochemistry Department Publications Trends: His work bridges pharmacology and cell biology, emphasizing stem cell pluripotency, neurodegenerative disease mechanisms, and aging-related biomarkers. Key themes include caloric restriction effects on amyloid accumulation and glial cell functions. Awards/Grants: Bridges to Stem Cell Research (BSCR) Program Advising & Mentorship: Supervised multiple student co-authors in stem cell and cancer biology research projects. Active in training through internships (BIOL 495C) and advanced seminars.

Official University Profile

Eduardo MaldonadoView profile

Associate Professor

Medical University of South CarolinaUnited States

Eduardo Maldonado is an Associate Professor in the Drug Discovery and Biomedical Sciences department at the College of Pharmacy, Medical University of South Carolina (MUSC) . His research focuses on mitochondrial metabolism in cancer cells, T cells, and cancer stem cells, particularly targeting mechanisms regulating Voltage-Dependent Anion Channels (VDAC) to develop therapeutic strategies. Education: DVM from Universidad Nacional del Centro (1986), PhD in Human Pathophysiology from Universidad Nacional del Sur (2001), Postdoctoral training at MUSC (2006, 2010), Predoctoral research at University of the Basque Country (1999). Research Interests: Mitochondrial metabolism regulation in cancer, VDAC-targeted small molecules, T cell immunometabolism, and cancer stem cell biology. His lab (established in 2015) explores how modulating VDAC channels through tubulin interactions or NADH-binding pockets can alter tumor proliferation and survival. Article Trends: Recent publications highlight VDAC's role in cancer bioenergetics, immunometabolic reprogramming (e.g., H2S-Prdx4 axis), and synergistic drug combinations. Earlier works emphasize mitochondrial ROS, lipid metabolism, and Golgi stress in disease contexts. Labs & Teams: Leads a research group at MUSC's College of Pharmacy, affiliated with the Developmental Cancer Therapeutics Program at Hollings Cancer Center. His work bridges mitochondrial physiology, cancer metabolism, and pharmacological intervention.

Official University Profile

Laura TiptonView profile

Assistant Professor

James Madison UniversityUnited States

Laura Tipton is an Assistant Professor in the Department of Mathematics & Statistics at James Madison University (JMU), affiliated with the College of Science and Mathematics. Her research focuses on microbiome dynamics across diverse habitats such as human lungs, aerobiota, invertebrate guts, and fermented foods, emphasizing bacterial-fungal interactions and robust statistical methodologies. She integrates techniques from ecology, machine learning, and graph theory, with side projects in digital humanities, data visualization, and data feminism. Education: PhD in Computational Biology (2016), University of Pittsburgh/Carnegie Mellon University MS in Statistics (2011), George Washington University BA in Biostatistics (2007), University of Virginia Her research interests span microbiome analysis, microbial interactions, and interdisciplinary data science. Recent work includes studies on airborne fungal DNA dynamics, fungal contributions to neonatal lung diseases, and psychobiotic field developments. She emphasizes methodological innovation in microbiome studies and advocates for inclusive data practices. While no formal awards or grants are listed, her work reflects significant contributions to collaborative projects like the Global Spore Sampling Project and Pacific Innovations, Knowledge, and Opportunities (PIKO) Program. Laura’s advising focuses on mentoring students in interdisciplinary projects at the intersection of mathematics, biology, and computational science.

Official University Profile

Gary HonView profile

Assistant Professor

University of Texas Southwestern Medical CenterUnited States

Dr. Gary Hon is an Assistant Professor at UT Southwestern Medical Center affiliated with the Cecil H. and Ida Green Center for Reproductive Biology Sciences and the Lyda Hill Department of Bioinformatics. He leads a research program focused on decoding the complexity of the human genome through two primary directions: understanding the molecular basis of cell state for regenerative medicine applications, and elucidating how non-coding variants contribute to development and disease. His lab employs integrative techniques at the interface of gene regulation, epigenetics, genome engineering, single-cell genomics, and bioinformatics. His research interests span genomics, epigenetics, bioinformatics, gene regulation, stem cell biology, and disease mechanisms. Dr. Hon earned his graduate degree from UC San Diego's Bioinformatics and Systems Biology Program and completed post-doctoral training in Dr. Bing Ren's lab before joining UT Southwestern in 2015. Dr. Hon has received significant recognition including the CPRIT Scholar award and NIH Director’s New Innovator Award. His recent publications demonstrate a focus on advanced genomic techniques including Perturb-Seq optimization, single-cell transcriptomics in cancer and reproductive biology, enhancer network mapping, and stem cell modeling of human development.

Official University Profile

Akinyemi I. OjesinaView profile

Assistant Professor

Medical College of WisconsinUnited States

Akinyemi I. Ojesina, MD, PhD is an Assistant Professor in the Department of Obstetrics & Gynecology at the Medical College of Wisconsin (MCW). He leads the Ojesina Oncopathogenomics Laboratory, which investigates the underlying causes of cancer through the lens of tumor ecology, where microbes synergize with genomic alterations to influence tumor initiation, progression, response to therapy, and prognosis. His work bridges translational genomics, metatranscriptomics, molecular epidemiology, and precision oncology. Dr. Ojesina's research program focuses on three primary areas: genomic characterization of molecular drivers in women's cancers, biology of atypical cervical cancers (particularly HPV-independent tumors), and the role of tumor microbiome in cancer initiation and progression. His laboratory applies cutting-edge genomic analyses and laboratory experiments to interrogate population-based patient samples, cell lines, and animal models. A key methodological contribution is his co-development of PathSeq, a computational tool for identifying microbial sequences in high-throughput sequencing data. His recent publications demonstrate a strong emphasis on cervical cancer genomics, with particular attention to HPV-related mechanisms, genomic alterations, and potential therapeutic targets. Across his work, Dr. Ojesina integrates multiple approaches including genomic sequencing, transcriptomic analysis, and functional validation to uncover novel insights into cancer biology, with implications for diagnostic biomarkers and predictive models in both local and global health contexts. Dr. Ojesina leads an active research team comprising postdoctoral researchers and fellows, and has secured significant funding from the National Cancer Institute for his project 'Molecular Markers for Tumors Associated with Extrachromosomal HPV' (2024-2029). His collaborative approach is evident in numerous multi-institutional publications, including major contributions to The Cancer Genome Atlas (TCGA) and other large consortia focused on cervical cancer genomics. His work has appeared in high-impact journals including Nature, Nature Genetics, and Cancer Cell.

Official University Profile

Mary Beth GrahamView profile

Professor

Medical College of WisconsinUnited States

Mary Beth Graham, MD, FIDSA, FACP is a Professor of Medicine with tenure at the Medical College of Wisconsin, where she serves as Associate Chief for the Division of Infectious Disease. She is also the Medical Director of Infection Prevention and Control at Froedtert Hospital and the Infection Prevention Program Director for the Medical College of Wisconsin. Dr. Graham is a Board Certified Internist and Infectious Disease specialist who joined the faculty at the Medical College of Wisconsin as an Assistant Professor of Medicine/Infectious Diseases in February 2002. Dr. Graham received her MD from Northwestern University Medical School in Chicago (1984), completed her Residency in Internal Medicine at the University of Washington Affiliated Hospitals in Seattle (1984-1987), and completed her Fellowship in Infectious Diseases at Washington University School of Medicine in St. Louis (1988-1991). Dr. Graham's clinical expertise includes HIV infection and associated complications, infections in immunocompromised individuals (including transplant recipients), influenza treatment and prevention, and the prevention of transmission of hospital-associated infections. She has an active outpatient clinical practice and also attends on the inpatient transplant and general infectious disease services. Her research has focused on infection control, particularly related to C. difficile, carbapenem-resistant organisms, and most recently on COVID-19 related complications including thrombosis and immune responses. Her publication record demonstrates a strong focus on clinical infectious disease research, with numerous studies on infections in immunocompromised hosts, antimicrobial resistance, and viral pathogenesis. Her work spans clinical trials, epidemiological studies, case reports, and immunological investigations, showing both clinical relevance and scientific rigor across multiple sub-specialties within infectious diseases. Best Doctors in America Top Doctor (Castle Connolly/Milwaukee Magazine) Best Teaching Physician at Froedtert Hospital by Department of Medicine residents (2013) MCW Outstanding Medical Student Teacher award (2015) Dr. Graham has demonstrated exceptional commitment to medical education, having received multiple teaching awards. As the Infectious Disease Fellowship Program Director, she plays a pivotal role in training the next generation of infectious disease specialists. Her administrative leadership in infection prevention and control reflects her significant contributions to hospital epidemiology and patient safety, with practical applications of her research directly impacting clinical practice and hospital policy. Dr. Graham maintains an active clinical practice with a focus on complex infectious disease cases, particularly in immunocompromised patients. Her dual expertise in clinical care and infection prevention makes her a key resource for managing challenging cases and developing institutional protocols for infection control.

Official University Profile